NCT01456897View on ClinicalTrials.gov

A Long-term Trial of OPC-34712 in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2015

Conditions
Schizophrenia
Interventions
DRUG

OPC-34712

orally administered once daily

Trial Locations (1)

Unknown

Kanto Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY